NCT01398202

Brief Summary

The purpose of this study is to investigate whether a supplement of 25-hydroxyvitamin D is five-times more potent in raising vitamin D status (as reflected by serum 25(OH)D) compared to an equivalent amount of vitamin D3 in older adults. It will entail a 10 week supplementation study during winter months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 20, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
Last Updated

December 2, 2015

Status Verified

November 1, 2015

Enrollment Period

6 months

First QC Date

July 18, 2011

Last Update Submit

November 30, 2015

Conditions

Keywords

Vitamin D status25-hydroxyvitamin DVitamin D3RCTBio-efficacy

Outcome Measures

Primary Outcomes (1)

  • serum 25-hydroxyvitamin D concentration

    10 weeks

Secondary Outcomes (4)

  • serum parathyroid hormone

    10 weeks

  • blood pressure

    10 weeks

  • biochemical markers of bone turnover

    10 weeks

  • serum calcium adjusted for albumin

    10 weeks

Study Arms (4)

Vitamin D3 (20 microgram/day)

ACTIVE COMPARATOR
Dietary Supplement: vitamin D3

25-hydroxyvitamin D (7 microgram/day)

ACTIVE COMPARATOR
Dietary Supplement: 25-hydroxyvitamin D3

25-hydroxyvitamin D3 (20 micogram/day)

ACTIVE COMPARATOR
Dietary Supplement: 25-hydroxyvitamin D (20 microgram/day)

Placebo

PLACEBO COMPARATOR
Dietary Supplement: Placebo

Interventions

vitamin D3DIETARY_SUPPLEMENT

20 micrograms per day for 10 weeks

Vitamin D3 (20 microgram/day)
25-hydroxyvitamin D3DIETARY_SUPPLEMENT

7 microgram/day for 10 weeks

25-hydroxyvitamin D (7 microgram/day)

20 microgramday for 10 weeks

25-hydroxyvitamin D3 (20 micogram/day)
PlaceboDIETARY_SUPPLEMENT

0 ug vitamin D3/25-hydroxyvitamin D3/day for 10 weeks

Placebo

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects will be eligible if they are 45+ years of age
  • Body Mass Index (BMI) 19-30

You may not qualify if:

  • have hypercalcaemia
  • chronic illness
  • renal or liver disorders
  • taking medications that might interact with vitamin D or metabolite
  • drank more than \> 21 standards (male)/ 14 standards (female) of alcohol per week
  • planning to change smoking habits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College Cork

Cork, Ireland

Location

Related Publications (1)

  • Cashman KD, Seamans KM, Lucey AJ, Stocklin E, Weber P, Kiely M, Hill TR. Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am J Clin Nutr. 2012 Jun;95(6):1350-6. doi: 10.3945/ajcn.111.031427. Epub 2012 May 2.

MeSH Terms

Interventions

CholecalciferolCalcifediol25-hydroxyvitamin D

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipidsHydroxycholecalciferols

Study Officials

  • Kevin D Cashman, PhD

    University College Cork

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Food and Health

Study Record Dates

First Submitted

July 18, 2011

First Posted

July 20, 2011

Study Start

January 1, 2011

Primary Completion

July 1, 2011

Study Completion

September 1, 2011

Last Updated

December 2, 2015

Record last verified: 2015-11

Locations